Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma
| dc.contributor.author | Gurnell, Mark | |
| dc.contributor.author | Domingo, Christian | |
| dc.contributor.author | Rabe, Klaus F | |
| dc.contributor.author | Menzies-Gow, Andrew | |
| dc.contributor.author | Price, David | |
| dc.contributor.author | Brusselle, Guy | |
| dc.contributor.author | Wechsler, Michael E | |
| dc.contributor.author | Xia, Changming | |
| dc.contributor.author | Pandit-Abid, Nami | |
| dc.contributor.author | Gall, Rebecca | |
| dc.contributor.author | Jacob-Nara, Juby A. | |
| dc.contributor.author | Rowe, Paul J. | |
| dc.contributor.author | Deniz, Yamo | |
| dc.contributor.author | Siddiqui, Shahid | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2023-11-30T00:06:29Z | |
| dc.date.available | 2023-11-30T00:06:29Z | |
| dc.date.embargoedUntil | 2023-11-30 | |
| dc.date.issued | 2022 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 1 | |
| dc.format.extent | 163872 | |
| dc.identifier | 284922253 | |
| dc.identifier | ab934c96-cda8-4107-93e5-24ceedb73f4c | |
| dc.identifier.citation | Gurnell, M, Domingo, C, Rabe, K F, Menzies-Gow, A, Price, D, Brusselle, G, Wechsler, M E, Xia, C, Pandit-Abid, N, Gall, R, Jacob-Nara, J A, Rowe, P J, Deniz, Y & Siddiqui, S 2022, 'Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma', European Respiratory Journal, vol. 60, no. Suppl. 66, 3620. https://doi.org/10.1183/13993003.congress-2022.3620 | en |
| dc.identifier.doi | 10.1183/13993003.congress-2022.3620 | |
| dc.identifier.issn | 0903-1936 | |
| dc.identifier.other | RIS: urn:DA3F8D460BB448BB40708E18DF4AEEDD | |
| dc.identifier.other | RIS: urn:DA3F8D460BB448BB40708E18DF4AEEDD | |
| dc.identifier.uri | https://hdl.handle.net/2164/22301 | |
| dc.identifier.url | http://erj.ersjournals.com/content/60/suppl_66/3620.abstract | en |
| dc.identifier.vol | 60 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | European Respiratory Journal | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Gurnell_etal_ERS2022_Dupilumab_Reduces_OCS_AAM.pdf
- Size:
- 160.03 KB
- Format:
- Adobe Portable Document Format
